【参考文献】

　　1  Grant PA,Berger SL,Workman JL,et al.Identification and analysis of native nucleosomal histone acetyltransferase complexes.Methods Mol Biol-Methods Mol Bio，1999,119:311.

　　2  Geiman TM,Robertaon KD,Williag HT,et al.Chromatin remodeling,histone modifications and DNA methylation-how dose it all fit together.J Cell Biochem,2002,87(2):117.

　　3  Brownell JE,Allis CD.Special HATs for special occasions:linking histon acetylation to chromatin assembly and gene activation.Curr Opin Genet Dev,1996,6(2):176-184.

　　4  Chen HW,Lacombe L,Montgomery K,et al.HATs on and beyond chromatin.Current opinion in cell biology Opinion in Cell Biology,2001,13:218.

　　5  Yang WM,Yao YL,Sun JM,et al. Isolation and characterization of cDNAs corresponding to an additional member of the human histon deacetylase gene family.J Biol Chem,1997,272(44):28001-28007.

　　6  Dangond F,Hafler DA,Tong JK,et al.Differential display cloning of a novel human histon deacetylase(HDAC3)cDNA from PHA-activeated immune cells.Biochem Biophys Res Commun,1998,242(3):648-652.

　　7  Emiliani S,Fishle W,Van Lint C,et al.Characterization of a human RPD3 ortholog,HDAC3. Proc Natl Acad Sci USA,1998,95(6):2795-2800.

　　8  Hu E,Chen ZX,Fredrickson T,et al.Cloning and characterization of a novel human class I histon deacetylase that functions as a transcription repressor. J Biol Chem,2000,275(20):15254-15264.

　　9  Zhou X,Marks PA ,Rifkind RA,et al.Cloning and characterization of a histon deacetylase .HDAC9,2001,98(19):10572-10577.

　　10  Fisher DD,Cai R,Bhatia U,et al.Isolation and characterization of a novel classII histon deacetylase.HDAC10.J Biol Chem,2002,277(18):6656-6666.

　　11  Frye RA.Characterization of five human cDNAs with homology to the yeast SIR2gene:Sir2-like proteins(sirtuins)metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun,1999,260(1):273-279.

　　12   Hu JF,Oruganti H, Vu TH,et al.The role of histone acetylation in the allelic expression of imprinted humain insulin-like growth factor II gene.Biochem Biophys Res Commun,1998,251(2):403.

　　13  Mark PA,Ricon VM,Rifkind RA.Histone deacetylase inhibitor:differentiation or apoptosis of transformed cells.J Nat Cancer Institute,2000,92:1210-1216.

　　14  Cress WD,Seto E.Histone deacetylase,transcriptional control and cancer.J Cell Physiol,2000,184:1-16.

　　15  Grunstein M.Histone acetylayion in chromatin structure and transcription.Nature,1997,389:345-352.

　　16  Mie Lee Y,Kim SH,Kim HS,et al.Inhibition of hypoxia-induced angiogenesis by FK228,a specific histone deacetylase inhibitor,via suppression of HIF-1a activity.Biochem Biophys Res Commun,2003,300(1):241-246.

　　17  Alon T,Hemo I,Itina A,et al. Vascular endothelial growth facter acts as a surrival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.Nat Med,1995,1:1024-1028.

　　18  Min JH,Yang H,Ivan M,et al.Structure of an HIF-1 alph-PVHL Complex:hydroxyproline recognition in signaling.Science,2002,296(5574):1886-1889.

　　19  Pham I,Uchida T,Planes C,et al.Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo.Am J Physiol Lung Cell Mol Physiol,2002,283(5):1133-1142.

　　20  Vanisman N,Gospodarowicz D,Neufeld G.Chracterization of the receptors for vascular endothelial growth factor .J Biol Chem,1990,265:19461.

　　21   Key BA, Nguyen HV,Berleau LT,et al.Identification of vascular endothelial growth factor determinants for binding KDR and flt-1 receptors.J Biol Chem,1996,271:5638.

　　22  Mousa SA,Lorelli W,Campochiaro PA.Role of hypoxa and extracelluar matrix-interin binding in the modulation of angiogenic growth factor secretion by retinal pigmented epithelial cells.J Cell Biochem,1999,74(1):135-143.

　　23  Blagosklonny MV.P53 inhibits hypoxia-inducible factor-stimulated transcription.J Biol Chem,1998,273,11995-11998.

　　24  Goto F,Toto K,Weindel K,et al.Synergistic effect of vascular endothelial growth factor on the proliferlation and cord formation of bovine capillary endothelial cells within collagen gels.Lab Invest,1993,69:508.

　　25  Krieg M.Up-regulation of hypoxia-inducible factors HIF-1a and Hif-2a under normoxic conditions in renal carcinoma cells by von hippel-lindau tumor suppressor gene loss of function .Oncogene,2000,19:5435-5443.

　　26  Strtamann R,Krieg M, Hass R,et al.Putative control of angiogenesis in hemangioblastomas by the von hippel-lindau tumor suppressor gene .J Neuropathol Exp Neurol,1997,56:1242-1252.

　　27  Pal S,Claffey KP,Dovrak HF,et al.The von hippel-lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.J Biol Chem,1997,272:27509-27512.

　　28  Lothar Rossig,Huige Li,Beat Fisslthaler,et al. Inhibitors of histon deacetylation downregulate the expression of endothrlial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis.Circ Res,2002,90:837-844.

　　29  Dimitrios Zgouras,Astrid Wachtershauser,Daniela Fings,et al. Butyrate impaies intestinal tumor cell-induced angiogenesis by inhibiting HIF-1a nuclear translocation .Biochem Biophys Res Commun,2003,832-838.

　　30  Kwon HJ,Kim MS,Kim MJ,et al.Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis.Int J Cancer,2002,97(3):290-296.

上一页  [1] [2] [3] [4] [5]